Table 1 Number of samples in each dataset of the studied diseases (myelodysplastic syndrome MDS, Alzheimer's disease AD and colorectal cancer CRC) divided in stages and ordered according to the progression of each disease
Disease subtypes and number of patient samples | ||||||
|---|---|---|---|---|---|---|
Myelodysplastic Synd. (MDS) | Control | RCUD | RCMD | RAEB1 | RAEB2 | AML |
Patient samples (N) | 11 | 6 | 17 | 4 | 5 | 10 |
Alzheimer’s disease (AD) | Control | Incipient | Moderate | Severe | ||
Patient samples (N) | 8 | 7 | 8 | 7 | ||
Colorectal cancer (CRC) | Control | Stage 1 | Stage 2 | Stage 3 | Stage 4 | |
Patient samples (N) | 25 | 13 | 37 | 34 | 20 | |